ÌÇÐÄÆƽâ°æ

In 2018 and 2020, cancer screening in the United States was generally lower among transgender adults compared to cisgender adults. The most significant difference was reported for cervical cancer, with 87 percent of cisgender adults screened, compared to 59 percent of transgender adults. This statistic depicts the prevalence of cancer screening among adults in the United States in 2018 and 2020, by gender identity.